BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Palmer ACS, Zortea M, Souza A, Santos V, Biazús JV, Torres ILS, Fregni F, Caumo W. Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: A randomized, double-blind, placebo-controlled trial. PLoS One 2020;15:e0231379. [PMID: 32302347 DOI: 10.1371/journal.pone.0231379] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 9.7] [Reference Citation Analysis]
Number Citing Articles
1 Seo K, Kim JH, Han D. Effects of Melatonin Supplementation on Sleep Quality in Breast Cancer Patients: A Systematic Review and Meta-Analysis. Healthcare (Basel) 2023;11. [PMID: 36900679 DOI: 10.3390/healthcare11050675] [Reference Citation Analysis]
2 Pinucci I, Maraone A, Tarsitani L, Pasquini M. Insomnia among Cancer Patients in the Real World: Optimising Treatments and Tailored Therapies. Int J Environ Res Public Health 2023;20. [PMID: 36900794 DOI: 10.3390/ijerph20053785] [Reference Citation Analysis]
3 Zhou L, Yang H, Wang J, Liu Y, Xu Y, Xu H, Feng Y, Ge W. The Therapeutic Potential of Antioxidants in Chemotherapy-Induced Peripheral Neuropathy: Evidence from Preclinical and Clinical Studies. Neurotherapeutics 2023. [PMID: 36735180 DOI: 10.1007/s13311-023-01346-8] [Reference Citation Analysis]
4 Oldacres L, Hegarty J, O'Regan P, Murphy-Coakley NM, Saab MM. Interventions promoting cognitive function in patients experiencing cancer related cognitive impairment: A systematic review. Psychooncology 2023;32:214-28. [PMID: 36443527 DOI: 10.1002/pon.6073] [Reference Citation Analysis]
5 Usmani MT, Krattli RP Jr, El-Khatib SM, Le ACD, Smith SM, Baulch JE, Ng DQ, Acharya MM, Chan A. BDNF Augmentation Using Riluzole Reverses Doxorubicin-Induced Decline in Cognitive Function and Neurogenesis. Neurotherapeutics 2023. [PMID: 36720792 DOI: 10.1007/s13311-022-01339-z] [Reference Citation Analysis]
6 Kheshti R, Dehghani M, Namazi S, Firouzabadi D, Mahmoudi L, Haem E. Effect of melatonin on oxaliplatin induced neuropathy in patients receiving FOLFOX and XELOX chemotherapy regimens for stage II-IV colorectal cancer; A randomized, placebo controlled, double blind trial.. [DOI: 10.21203/rs.3.rs-2428741/v1] [Reference Citation Analysis]
7 Yin W, Zhang J, Guo Y, Wu Z, Diao C, Sun J. Melatonin for premenstrual syndrome: A potential remedy but not ready. Front Endocrinol (Lausanne) 2022;13:1084249. [PMID: 36699021 DOI: 10.3389/fendo.2022.1084249] [Reference Citation Analysis]
8 Chen L, Xu S, Jia Z, Tan Y, Shi X, Lin X. Comparative efficacy of different acupuncture therapies on cancer-related insomnia: protocol for a systematic review and network meta-analysis. BMJ Open 2022;12:e064181. [PMID: 36600339 DOI: 10.1136/bmjopen-2022-064181] [Reference Citation Analysis]
9 Feizabadi F, Abedini A, Salamzadeh J, Barati S, Dastan F. Study of the Effects of Melatonin on Sleep Disorders in Pulmonary Sarcoidosis Patients. Iran J Pharm Res 2022;21:e132168. [PMID: 36896316 DOI: 10.5812/ijpr-132168] [Reference Citation Analysis]
10 Oppegaard KR, Armstrong TS, Anguera JA, Kober KM, Debr LK, Laister RC, Saligan LN, Ayala AP, Kuruvilla J, Alm MW, Byker WH, Miaskowski C, Mayo SJ. Blood-Based Biomarkers of Cancer-Related Cognitive Impairment in Non-Central Nervous System Cancer: A Scoping Review. Crit Rev Oncol Hematol 2022;:103822. [PMID: 36152911 DOI: 10.1016/j.critrevonc.2022.103822] [Reference Citation Analysis]
11 Fraile-martinez O, Alvarez-mon MA, Garcia-montero C, Pekarek L, Guijarro LG, Lahera G, Saez MA, Monserrat J, Motogo D, Quintero J, Alvarez-mon M, Ortega MA. Understanding the basis of major depressive disorder in oncological patients: Biological links, clinical management, challenges, and lifestyle medicine. Front Oncol 2022;12:956923. [DOI: 10.3389/fonc.2022.956923] [Reference Citation Analysis]
12 Fan R, Bu X, Yang S, Tan Y, Wang T, Chen H, Li X. Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials. BMJ Open 2022;12:e060912. [PMID: 36104141 DOI: 10.1136/bmjopen-2022-060912] [Reference Citation Analysis]
13 Gall AJ, Shuboni-mulligan DD. Keep Your Mask On: The Benefits of Masking for Behavior and the Contributions of Aging and Disease on Dysfunctional Masking Pathways. Front Neurosci 2022;16:911153. [DOI: 10.3389/fnins.2022.911153] [Reference Citation Analysis]
14 Shokri-mashhadi N, Darand M, Rouhani MH, Yahay M, Feltham BA, Saraf-bank S. Effects of melatonin supplementation on BDNF concentrations and depression: A systematic review and meta-analysis of randomized controlled trials. Behavioural Brain Research 2022. [DOI: 10.1016/j.bbr.2022.114083] [Reference Citation Analysis]
15 Lucius K. Melatonin Beyond Sleep, Part II: Focus on Oncology. Integrative and Complementary Therapies 2022;28:189-194. [DOI: 10.1089/ict.2022.29031.klu] [Reference Citation Analysis]
16 Ng DQ, Chan D, Agrawal P, Zhao W, Xu X, Acharya M, Chan A. EVIDENCE OF BRAIN-DERIVED NEUROTROPHIC FACTOR IN AMELIORATING CANCER-RELATED COGNITIVE IMPAIRMENT: A SYSTEMATIC REVIEW OF HUMAN STUDIES. Crit Rev Oncol Hematol 2022;:103748. [PMID: 35718064 DOI: 10.1016/j.critrevonc.2022.103748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Muñoz-Jurado A, Escribano BM, Caballero-Villarraso J, Galván A, Agüera E, Santamaría A, Túnez I. Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action. Inflammopharmacology 2022. [PMID: 35665873 DOI: 10.1007/s10787-022-01011-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Al-naggar R, Al-maktari L. Artificial Light at Night and Breast Cancer. Light Pollution, Urbanization and Ecology 2022. [DOI: 10.5772/intechopen.96896] [Reference Citation Analysis]
19 Sadoughi F, Dana PM, Asemi Z, Shafabakhash R, Mohammadi S, Heidar Z, Mirzamoradi M, Targhazeh N, Mirzaei H. Molecular and cellular mechanisms of melatonin in breast cancer. Biochimie 2022:S0300-9084(22)00067-0. [PMID: 35341930 DOI: 10.1016/j.biochi.2022.03.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
20 Wei Y, Zhang C, Wang D, Wang C, Sun L, Chen P. Progress in Research on the Effect of Melatonin on Postoperative Cognitive Dysfunction in Older Patients. Front Aging Neurosci 2022;14:782358. [DOI: 10.3389/fnagi.2022.782358] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Das NK, Samanta S. The potential anti-cancer effects of melatonin on breast cancer. Exploration of Medicine. [DOI: 10.37349/emed.2022.00078] [Reference Citation Analysis]
22 Li C, Ma D, Li M, Wei T, Zhao X, Heng Y, Ma D, Anto EO, Zhang Y, Niu M, Zhang W. The Therapeutic Effect of Exogenous Melatonin on Depressive Symptoms: A Systematic Review and Meta-Analysis. Front Psychiatry 2022;13:737972. [PMID: 35370838 DOI: 10.3389/fpsyt.2022.737972] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Fatemeh G, Sajjad M, Niloufar R, Neda S, Leila S, Khadijeh M. Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials. J Neurol 2022;269:205-16. [PMID: 33417003 DOI: 10.1007/s00415-020-10381-w] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 26.0] [Reference Citation Analysis]
24 Megerian MF, Kim JS, Badreddine J, Hong SH, Ponsky LE, Shin JI, Ghayda RA. Melatonin and Prostate Cancer: Anti-tumor Roles and Therapeutic Application. Aging and disease 2022. [DOI: 10.14336/ad.2022.1010] [Reference Citation Analysis]
25 David A, Hausner D, Frenkel M. Cancer-Related Fatigue-Is There a Role for Complementary and Integrative Medicine? Curr Oncol Rep 2021;23:145. [PMID: 34743258 DOI: 10.1007/s11912-021-01135-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Ribeiro IL, González XG, Torres DL, Lorca LA, Dixit S, Benavides NY, Gonzalez FO. Signs of Central Hypersensitivity, Stress, and Anxiety following Treatment for Breast Cancer: A Case Control Study. Int J Breast Cancer 2021;2021:5691584. [PMID: 34707910 DOI: 10.1155/2021/5691584] [Reference Citation Analysis]
27 Cichon N, Dziedzic A, Gorniak L, Miller E, Bijak M, Starosta M, Saluk-Bijak J. Unusual Bioactive Compounds with Antioxidant Properties in Adjuvant Therapy Supporting Cognition Impairment in Age-Related Neurodegenerative Disorders. Int J Mol Sci 2021;22:10707. [PMID: 34639048 DOI: 10.3390/ijms221910707] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Zhou L, Zhang C, Yang X, Liu L, Hu J, Hou Y, Tao H, Sugimura H, Chen Z, Wang L, Chen K. Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1. Clin Transl Med 2021;11:e449. [PMID: 34185414 DOI: 10.1002/ctm2.449] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
29 Jafari-Koulaee A, Bagheri-Nesami M. The effect of melatonin on sleep quality and insomnia in patients with cancer: a systematic review study. Sleep Med 2021;82:96-103. [PMID: 33910162 DOI: 10.1016/j.sleep.2021.03.040] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
30 Liu D, Shi K, Fu M, Chen F. Melatonin indirectly decreases gastric cancer cell proliferation and invasion via effects on cancer-associated fibroblasts. Life Sci 2021;277:119497. [PMID: 33864820 DOI: 10.1016/j.lfs.2021.119497] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
31 Smorodin ЕР. RELEVANCE OF FURTHER CLINICAL TRIALS OF THE USE OF MELATONIN IN ADJUVANT CANCER THERAPY. Rossijskij bioterapevtičeskij žurnal 2021;20:24-32. [DOI: 10.17650/1726-9784-2021-20-1-24-32] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Gurunathan S, Qasim M, Kang MH, Kim JH. Role and Therapeutic Potential of Melatonin in Various Type of Cancers. Onco Targets Ther 2021;14:2019-52. [PMID: 33776451 DOI: 10.2147/OTT.S298512] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
33 Sedighi Pashaki A, Mohammadian K, Afshar S, Gholami MH, Moradi A, Javadinia SA, Keshtpour Amlashi Z. A Randomized, Controlled, Parallel-Group, Trial on the Effects of Melatonin on Fatigue Associated with Breast Cancer and Its Adjuvant Treatments. Integr Cancer Ther 2021;20:1534735420988343. [PMID: 33543655 DOI: 10.1177/1534735420988343] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
34 Liu PI, Chang AC, Lai JL, Lin TH, Tsai CH, Chen PC, Jiang YJ, Lin LW, Huang WC, Yang SF, Tang CH. Melatonin interrupts osteoclast functioning and suppresses tumor-secreted RANKL expression: implications for bone metastases. Oncogene 2021;40:1503-15. [PMID: 33452455 DOI: 10.1038/s41388-020-01613-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
35 Griñan-Lison C, Blaya-Cánovas JL, López-Tejada A, Ávalos-Moreno M, Navarro-Ocón A, Cara FE, González-González A, Lorente JA, Marchal JA, Granados-Principal S. Antioxidants for the Treatment of Breast Cancer: Are We There Yet? Antioxidants (Basel) 2021;10:205. [PMID: 33572626 DOI: 10.3390/antiox10020205] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
36 Danilovich ME, Alberto MR, Juárez Tomás MS. Microbial production of beneficial indoleamines (serotonin and melatonin) with potential application to biotechnological products for human health. J Appl Microbiol 2021. [PMID: 33484616 DOI: 10.1111/jam.15012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Moloudizargari M, Moradkhani F, Hekmatirad S, Fallah M, Asghari MH, Reiter RJ. Therapeutic targets of cancer drugs: Modulation by melatonin. Life Sci 2021;267:118934. [PMID: 33385405 DOI: 10.1016/j.lfs.2020.118934] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
38 Lv L, Mao S, Dong H, Hu P, Dong R. Pathogenesis, Assessments, and Management of Chemotherapy-Related Cognitive Impairment (CRCI): An Updated Literature Review. J Oncol 2020;2020:3942439. [PMID: 32684930 DOI: 10.1155/2020/3942439] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]